
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cingulate (NASDAQ:CINGW) through any online brokerage.
Other companies in Cingulate’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Cingulate to provide a consensus price target.
The stock price for Cingulate (NASDAQ: CINGW) is $0.01 last updated October 16, 2026 at 10:05 AM EDT.
There are no upcoming dividends for Cingulate.
Cingulate does not have any upcoming earnings scheduled.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an...